Oxybutynin Tablet, Film Coated, Extended Release
Product Images NDC 68382-257

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Oxybutynin (NDC 68382-257). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 01

Chemical structure of oxybutynin hydrochloride, showing the molecular arrangement including phenyl ring, ester, alkyne, and amine groups.*

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 02

A line graph comparing mean plasma R-oxybutynin concentration (ng/mL) over 24 hours for oxybutynin chloride extended-release tablets 10 mg once daily (QD) and oxybutynin 5 mg three times daily (TID). The x-axis shows time in hours, and the y-axis shows concentration with error bars indicating variability.*

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 03

A line graph depicting mean R-oxybutynin plasma concentration (ng/mL) over time (hours) up to 24 hours. The graph displays data points with error bars, showing concentration values peaking around 4 to 6 hours and gradually decreasing thereafter.*

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 04

A horizontal dot plot chart comparing oxybutynin chloride extended-release tablets and placebo. It shows mean values with error bars on a scale ranging roughly from -40 to 40, with oxybutynin chloride positioned around -15 and placebo positioned around -5, each with corresponding error bars.*

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 05

A horizontal error bar chart comparing oxybutynin chloride extended-release tablets and oxybutynin. The x-axis ranges from -40 to 40, and the chart shows points and associated error bars for both items on the left side of the zero mark.*

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 06

A horizontal error bar chart comparing two items labeled 'Oxybutynin chloride extended-release tablets' and 'Oxybutynin' along a numerical axis ranging approximately from -40 to 40. The chart shows the central points and error ranges for each label, without additional context or axis titles visible.*

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 07

Label for Oxybutynin Chloride Extended-Release Tablets, USP 5 mg, film-coated oral tablets by Zydus Pharmaceuticals USA Inc. The label indicates 100 tablets in the package with instructions to swallow whole and not to chew, divide, or crush tablets. It includes storage guidelines, manufacturer information (Cadila Healthcare Ltd., India), and distributor details (Zydus Pharmaceuticals USA Inc., Pennington, NJ).*

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 08

Label for Oxybutynin Chloride Extended-Release Tablets, USP, 10 mg strength. The label shows a round film-coated tablet embossed with "256". The product is supplied as 100 tablets for oral use, manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals USA Inc. Dosage instructions and storage conditions are included on the label.*

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 09

Label for Oxybutynin Chloride Extended-Release Tablets, USP, 15 mg film-coated oral tablets. The label shows a round tablet embossed with '257' and provides dosage and storage instructions. The product is made by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals USA Inc., with packaging containing 100 tablets for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.